Correlation Between ALBIS LEASING and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both ALBIS LEASING and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ALBIS LEASING and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ALBIS LEASING AG and Takeda Pharmaceutical, you can compare the effects of market volatilities on ALBIS LEASING and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ALBIS LEASING with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of ALBIS LEASING and Takeda Pharmaceutical.

Diversification Opportunities for ALBIS LEASING and Takeda Pharmaceutical

-0.54

Correlation Coefficient

ALBIS LEASING  Takeda Pharmaceutical

Excellent diversification

The 3 months correlation between ALBIS and Takeda is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding ALBIS LEASING AG and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and ALBIS LEASING is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ALBIS LEASING AG are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of ALBIS LEASING i.e., ALBIS LEASING and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between ALBIS LEASING and Takeda Pharmaceutical

Assuming the 90 days trading horizon ALBIS LEASING AG is expected to generate 0.7 times more return on investment than Takeda Pharmaceutical. However, ALBIS LEASING AG is 1.44 times less risky than Takeda Pharmaceutical. It trades about 0.07 of its potential returns per unit of risk. Takeda Pharmaceutical is currently generating about -0.02 per unit of risk. If you would invest  205.00  in ALBIS LEASING AG on October 4, 2024 and sell it today you would earn a total of  69.00  from holding ALBIS LEASING AG or generate 33.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ALBIS LEASING AG  vs.  Takeda Pharmaceutical

ALBIS LEASING AG

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ALBIS LEASING AG are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, ALBIS LEASING is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with ALBIS LEASING and Takeda Pharmaceutical

The main advantage of trading using opposite ALBIS LEASING and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ALBIS LEASING position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind ALBIS LEASING AG and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.